MB "Biodetoksa" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 10,210 |
| - |
| -827 |
| -827 |
| - |
| 100.00 |
| -8.10 |
| 6,000 |
| 534 |
| 666 |
| 5,868 |
| 0.52 |
| 0.09 |
| - |
| - |
| -8.10 |
| -827 |
| 2024 |
|---|
| 12,395 |
| - |
| 1,197 |
| 1,178 |
| - |
| 100.00 |
| 9.50 |
| 7,178 |
| 534 |
| 376 |
| 7,336 |
| 0.55 |
| 0.07 |
| - |
| - |
| 9.66 |
| 1,197 |
| 2025 |
|---|
| 15,116 |
| - |
| -2,779 |
| -2,779 |
| - |
| 100.00 |
| -18.38 |
| 4,399 |
| 2,492 |
| 708 |
| 6,183 |
| 0.24 |
| 0.57 |
| - |
| - |
| -18.38 |
| -2,779 |
| 2025 |
|---|
| 15,116 |
| - |
| -2,779 |
| -2,779 |
| - |
| 100.00 |
| -18.38 |
| 4,399 |
| 2,492 |
| 708 |
| 6,183 |
| 0.24 |
| 0.57 |
| - |
| - |
| -18.38 |
| -2,779 |
Turnover (€)
2025
Turnover (€)
15,116 €22 % *
Sales per employee (€)
-Profit before tax (€)
-2,779 €-332 % *
Net Profit (€)
-2,779 €-336 % *
Profit per employee (€)
-Total profitability (%)
100.00 %0.00 % *
Net profitability (%)
-18.38 %-293.47 % *
Equity (€)
4,399 €-39 % *
Amounts Payable And Liabilities (€)
2,492 €367 % *
Non-current Assets (€)
708 €88 % *
CurrentAssets (€)
6,183 €-16 % *
Working capital requirement
0.24 -56.36 % *
Debt-to-equity ratio
0.57 714.29 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
-18.38 %-290.27 % *
EBIT (€)
-2,779 €-332 % *
